Strategic Advisory Board of the School of Pharmacy and Pharmaceutical Sciences
The Strategic Advisory Board (SAB) was established in early 2015 to review and guide the strategy of the School of Pharmacy and Pharmaceutical Sciences, with a view to maintaining and building on internationally recognised excellence. It is composed of respected experts, whose names were proposed by the Head of School and then approved by the School Executive Committee.
The School’s current Strategic Advisory Board members are:
- Dr Aoife Brennan, CEO, Synlogic Therapeutics
- Mr Patrick Byrne, Community Pharmacist, Byrne's Life Pharmacy
- Dr Michele Cleary, Head US Scientific Collaborations, Bristol Myers Squibb
- Prof Mark Ledwidge, Adjunct Professor, The School of Medicine, University College Dublin
- Prof Mary McCarron, School of Nursing & Midwifery, Trinity College Dublin
- Mr Seamus Mulligan, Chairman & Chief Executive Officer, Adapt Pharma
- Mr Paul Tighe, Head of Pharmacy Services, St. Vincent's University Hospital